-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$5.50N/A% Upside
eFFECTOR Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover eFFECTOR Therapeutics, Inc.?
eFFECTOR Therapeutics, Inc. has been rated by research analysts at Stifel Nicolaus, JMP Securities in the past 90 days.